Limits...
Hyperplastic cardiac sarcoma recurrence.

Shariff MA, Abreu JA, Durrani F, Daniele E, Bowman KC, Sadel S, Asgarian KT, McGinn JT, Nabagiez JP - Case Rep Surg (2015)

Bottom Line: Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months.Data suggest that an aggressive multidisciplinary approach may improve patient outcome.This report discusses the malignant nature of cardiac sarcoma and the importance of postoperative multidisciplinary care.

View Article: PubMed Central - PubMed

Affiliation: Department of Cardiothoracic Surgery, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.

ABSTRACT
Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months. Data suggest that an aggressive multidisciplinary approach may improve patient outcome. We present the case of a male who underwent resection of cardiac sarcoma three times from the age of 32 to 34. This report discusses the malignant nature of cardiac sarcoma and the importance of postoperative multidisciplinary care.

No MeSH data available.


Related in: MedlinePlus

Presentation 3. CT-scan showing tumor of the intra-atrial septum in the left atrium, nongated scan.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4377465&req=5

fig4: Presentation 3. CT-scan showing tumor of the intra-atrial septum in the left atrium, nongated scan.

Mentions: A CT scan in March of 2011 revealed a 2.8 × 3.7 cm left atrial recurrence 10 weeks after completion of chemotherapy. TTE revealed an echogenic density in the left atrium originating in the interatrial septum (Figure 4). Redo-sternotomy was performed with cardiopulmonary bypass. Tumor was resected from the interatrial septum in the vicinity of the previously placed patch, including the left superior and inferior pulmonary veins. Resection continued over the anterior leaflet of the mitral valve annulus. Pathology confirmed negative margins inferior to the interatrial septum, but microscopic disease was noted on the posterior mass adjacent to the mitral valve leaflet connecting to the ostium of the pulmonary veins. Resection of the latter was impossible without resecting the entire fibrous trigone of the heart and possible left pneumonectomy. The interatrial septum and the free wall of the left and the right atrium were reconstructed with bovine pericardium. Pathology revealed a high-grade spindle cell and pleomorphic sarcoma. The patient was discharged on postoperative day six.


Hyperplastic cardiac sarcoma recurrence.

Shariff MA, Abreu JA, Durrani F, Daniele E, Bowman KC, Sadel S, Asgarian KT, McGinn JT, Nabagiez JP - Case Rep Surg (2015)

Presentation 3. CT-scan showing tumor of the intra-atrial septum in the left atrium, nongated scan.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4377465&req=5

fig4: Presentation 3. CT-scan showing tumor of the intra-atrial septum in the left atrium, nongated scan.
Mentions: A CT scan in March of 2011 revealed a 2.8 × 3.7 cm left atrial recurrence 10 weeks after completion of chemotherapy. TTE revealed an echogenic density in the left atrium originating in the interatrial septum (Figure 4). Redo-sternotomy was performed with cardiopulmonary bypass. Tumor was resected from the interatrial septum in the vicinity of the previously placed patch, including the left superior and inferior pulmonary veins. Resection continued over the anterior leaflet of the mitral valve annulus. Pathology confirmed negative margins inferior to the interatrial septum, but microscopic disease was noted on the posterior mass adjacent to the mitral valve leaflet connecting to the ostium of the pulmonary veins. Resection of the latter was impossible without resecting the entire fibrous trigone of the heart and possible left pneumonectomy. The interatrial septum and the free wall of the left and the right atrium were reconstructed with bovine pericardium. Pathology revealed a high-grade spindle cell and pleomorphic sarcoma. The patient was discharged on postoperative day six.

Bottom Line: Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months.Data suggest that an aggressive multidisciplinary approach may improve patient outcome.This report discusses the malignant nature of cardiac sarcoma and the importance of postoperative multidisciplinary care.

View Article: PubMed Central - PubMed

Affiliation: Department of Cardiothoracic Surgery, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.

ABSTRACT
Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months. Data suggest that an aggressive multidisciplinary approach may improve patient outcome. We present the case of a male who underwent resection of cardiac sarcoma three times from the age of 32 to 34. This report discusses the malignant nature of cardiac sarcoma and the importance of postoperative multidisciplinary care.

No MeSH data available.


Related in: MedlinePlus